Sébastien Salas - Concepedia

Author

Sébastien Salas

Also Known As

Audrey Monneur, François Bertucci, Rossitza Krasteva Ruseva, S Bastien Salas, S Salas, S. SALAS, S. Salas, S??bastien Salas, Salas, S., Salas, Sebastien

315

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Hôpital de la Timone Aix-Marseille Université Centre Léon Bérard Inserm Institut Gustave Roussy

About

Sébastien Salas is an author at Hôpital de la Timone specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	41	3.1K
2	Health Sciences	8	8	467
3	Nursing	2	2	108
4	Engineering	1	1	324
5	Public Health	1	1	59

Sébastien Salas

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity Frédéric Chibon, Pauline Lagarde, Sébastien Salas, Nature Medicine Gene Expression SignatureClinical OutcomeTumor HeterogeneityMultiple TypesMedicine	2010	450
Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation Sébastien Salas, Armelle Dufresne, Binh Bui, Journal of Clinical Oncology	2011	368
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters François Bertucci, Sébastien Salas, Séverine Eysteries, Oncogene Functional GenomicsEngineeringMedicineMicroarray Data AnalysisDna Microarrays	2004	324
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial Olivier Mir, Thomas Brodowicz, Antoîne Italiano, The Lancet Oncology OncologyMetronomic TherapyClinical TrialsPharmacotherapyCancer Treatment	2016	276
A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis Aimeé M. Crago, Brian T. Denton, Sébastien Salas, Annals of Surgery	2013	266
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot, European Journal of Cancer FibrosisSurgical PathologyPathologyNationwide Prospective CohortMedicine	2017	178
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study Shubham Pant, Martin Schüler, Gopa Iyer, The Lancet Oncology Fgfr AlterationsMedicinePathologyAdvanced Solid TumoursFibroblast Growth Factor	2023	175
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay, Annals of Oncology Risk CalculatorSurgical OncologySolitary Fibrous TumorTumor HeterogeneityMedicine	2017	167
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG) Delphine Garbay, Axel Le Cesne, Nicolas Penel, Annals of Oncology Malignant DiseaseMedicinePathologyFrench Sarcoma GroupCancer Treatment	2011	159
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho, Journal for ImmunoTherapy of Cancer	2020	153

Page 1